Coherus Oncology, Inc. (CHRS)

1.63 -0.06 (-3.55%) USD  |  NASDAQ  |  Mar 13, 16:00
1.635 0.00 (0.00%) After-Hours: 20:00
More

Coherus Oncology Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for CHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Johnson & Johnson Upgrade
Stereotaxis, Inc. Upgrade
Allogene Therapeutics, Inc. Upgrade
Inovio Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade